Aripiprazole for Delusional Disorder: Dosing Recommendations
Yes, you can increase the aripiprazole dose from 15 mg to 20-30 mg/day for delusional disorder, as the FDA-approved range for psychotic disorders is 10-30 mg/day, and research specifically in delusional disorder shows average effective doses around 11 mg/day with good tolerability up to higher doses. 1, 2
Evidence-Based Dosing Strategy
Current Dose Assessment
Your patient is on 15 mg, which is within the therapeutic range but may not be optimized. The FDA label for schizophrenia (the closest approved indication) states that doses higher than 10-15 mg/day were not consistently more effective in trials, but the approved range extends to 30 mg/day 1. However, dosage increases should not be made before 2 weeks to allow steady-state achievement 1.
Specific Recommendations for Delusional Disorder
Aripiprazole is an excellent choice for delusional disorder based on:
- A systematic review of 21 cases showing clinical improvement in delusional disorder at an average dose of 11.1 mg/day with response time of 5.7 weeks 2
- Good tolerability profile with minimal side effects (asthenia, extrapyramidal symptoms, hyperprolactinemia, insomnia) 2
- A large Swedish registry study (9,076 patients) found oral aripiprazole reduced work disability risk by 48% in delusional disorder 3
Dose Optimization Algorithm
If inadequate response after 4 weeks at 15 mg:
- Increase to 20 mg/day - This is supported by dose-response data showing optimal efficacy between 10-25 mg/day for psychotic symptoms 4
- Wait another 2-4 weeks for full assessment at the new dose 1
- If still inadequate, increase to 25-30 mg/day - A meta-analysis found high-dose strategies (>15 mg/day) showed significantly greater PANSS reductions, particularly in long-term treatment (>8 weeks) 5
Important Caveats
Do not exceed 30 mg/day - The FDA label explicitly states safety above 30 mg/day has not been evaluated 1, and research suggests doses above 20-25 mg/day may not provide additional benefit and could reduce efficacy 4, 6
Dose adjustments must be gradual - Increase in 5 mg increments at intervals of at least 1 week 1
Check for drug interactions - If your patient is on CYP3A4 or CYP2D6 inhibitors, dose adjustments are required (reduce to half the usual dose for strong inhibitors) 1
Alternative Considerations
If aripiprazole fails at optimized doses, the Swedish registry data suggests clozapine (76% risk reduction) and long-acting injectables (72% risk reduction for hospitalization) are most effective for delusional disorder 3. The 2025 schizophrenia guidelines recommend switching to an antipsychotic with a different pharmacodynamic profile if first-line treatment fails after 4 weeks at therapeutic dose 7. Since aripiprazole is a D2 partial agonist, switching to a D2 antagonist like olanzapine or a long-acting injectable would be the logical next step.
Monitoring
Reassess symptoms every 2-4 weeks during dose titration. The average time to clinical response in delusional disorder is 5.7 weeks 2, so patience is required. Monitor for akathisia and metabolic effects, though aripiprazole has a favorable side-effect profile compared to other antipsychotics 2.